We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Kinase Assay Optimized

By Biotechdaily staff writers
Posted on 08 May 2007
A flexible and adaptable homogeneous technology for high-throughput screening (HTS) and ultra HTS (uHTS) was designed specifically for developing and optimizing sensitive assays for a variety of drug discovery targets, with a particular focus on applications for a wide range of kinase targets.

PerkinElmer, Inc. More...
(Waltham, MA, USA), announced that it has expanded its successful portfolio of HTS Lance assays with the release of Lance Ultra. The improved time-resolved fluorescence resonance energy transfer (TR-FRET) technology accelerates speed and precision of kinase assay development and optimization.

"Protein kinases regulate several important functions within cells, such as growth, proliferation, and cell adhesion, making it one of the most important areas of study in today's pharmaceutical and biotech laboratories,” said Dr. Richard Eglen, vice president and general manager of the Discovery and Research Reagents business of PerkinElmer Life and Analytical Sciences. "The addition of Lance Ultra to PerkinElmer's broad offering of TR-FRET assay tools creates one of the industry's largest portfolios targeting high value functional biochemical and cell based assays.”

Lance Ultra utilizes ULight, an innovative, low-molecular weight red-shifted fluorescent dye that greatly enhances the performance of TR-FRET assays by increasing the range of targets that can be identified. Dr. Eglen said, "Dysregulation of kinase activity plays causal roles in many human diseases, making kinases one of today's most important drug discovery target classes.”

Lance Ultra reagents are specifically engineered for the precise development and optimization of kinase and enzyme assays, as well as for monitoring protein-protein interactions. Ultra high throughput screening applications such as Lance Ultra are easily adapted to any TR-FRET capable plate reader such as the PerkinElmer ViewLux uHTS imaging system or EnVision multimode reader, enabling greatly improved precision and remarkable throughput.

In addition to its broad range of traditional Lance technologies, PerkinElmer has significantly enhanced its custom reagents service, offering expert labeling of a wide variety of peptides, proteins and antibodies with PerkinElmer's proprietary europium and lanthanide chelate donor dyes, and ULight or allophycocyanin (APC) acceptor dyes.


Related Links:
PerkinElmer

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: DOA Urine MultiPlex is available on the fully automated Evidence MultiSTAT multi‑analyte analyzer (Photo courtesy of Randox)

Rapid Testing Panel Simultaneously Detects 15 Drugs of Abuse in Urine Within 21 Minutes

Illicit drug use and excessive use of prescription medicine is growing across the US amid a severe opioid crisis. Although overdose fatalities were reported to have declined by nearly 27% in 2024, many... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.